Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial.
Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial. — المؤلف: Kim, Hee-Je — Bone marrow transplantation 20200706
- المؤلف
- Kim, Hee-Je
- النشر
- Bone marrow transplantation 20200706
- الوصف
- 903-906 p.
- الموضوعات
- Adult؛ Female؛ Humans؛ Immunotherapy؛ Leukemia, Myeloid, Acute؛ Male؛ Middle Aged؛ Prospective Studies